Fortescue Ltd
Fortescue Ltd (FMG.AX) Financial Performance & Income Statement Overview
Review Fortescue Ltd (FMG.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Fortescue Ltd (FMG.AX) Income Statement & Financial Overview
Explore comprehensive income reports for Fortescue Ltd FMG.AX, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $8.71B | $9.51B | $9.04B | $7.83B |
| Cost of Revenue | $4.61B | $4.07B | $3.88B | $3.94B |
| Gross Profit | $4.10B | $5.45B | $5.16B | $3.89B |
| Gross Profit Ratio | $0.47 | $0.57 | $0.57 | $0.50 |
| R&D Expenses | $271.00M | $224.00M | $273.00M | $280.00M |
| SG&A Expenses | $285.00M | $227.00M | $278.00M | $180.00M |
| Operating Expenses | $571.00M | $487.00M | $1.63B | $456.00M |
| Total Costs & Expenses | $5.18B | $4.55B | $5.51B | $4.40B |
| Interest Income | $0.00 | $101.21M | $86.51M | $62.24M |
| Interest Expense | $0.00 | $194.08M | $156.30M | $118.35M |
| Depreciation & Amortization | $1.07B | $922.00M | $727.00M | $859.00M |
| EBITDA | $4.59B | $5.92B | $5.31B | $4.28B |
| EBITDA Ratio | $0.53 | $0.62 | $0.59 | $0.55 |
| Operating Income | $3.53B | $4.96B | $4.59B | $3.42B |
| Operating Income Ratio | $0.41 | $0.52 | $0.51 | $0.44 |
| Other Income/Expenses (Net) | -$91.00M | -$98.00M | -$75.00M | -$24.00M |
| Income Before Tax | $3.44B | $4.86B | $3.49B | $3.40B |
| Income Before Tax Ratio | $0.40 | $0.51 | $0.39 | $0.43 |
| Income Tax Expense | $1.11B | $1.53B | $1.06B | $1.03B |
| Net Income | $2.35B | $3.34B | $2.43B | $2.37B |
| Net Income Ratio | $0.27 | $0.35 | $0.27 | $0.30 |
| EPS | $0.76 | $1.08 | $0.79 | $0.77 |
| Diluted EPS | $0.76 | $1.08 | $0.79 | $0.77 |
| Weighted Avg Shares Outstanding | $3.08B | $3.08B | $3.08B | $3.08B |
| Weighted Avg Shares Outstanding (Diluted) | $3.08B | $3.08B | $3.08B | $3.08B |
Financial performance has remained strong, with revenue growing from $7.83B in Q2 2023 to $8.71B in Q4 2024. Gross profit continued to perform well, with margins at 47% in the latest quarter. Operating income reached $3.53B in Q4 2024, holding a steady 41% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $4.59B. Net income dropped to $2.35B, keeping EPS at $0.76. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan